{"entity":{"id":"frantz-viral-therapeutics","kind":"company","name":"Frantz Viral Therapeutics","aka":["Frantz Viral Therapeutics, LLC"],"tldr":"Frantz Viral Therapeutics is a US-based biotechnology company that leads 2 cancer trials in OnCo, testing self-administered artesunate inserts and ointment for HPV-related pre-cancers in vaginal cancer and vulvar cancer.","summary":"Frantz Viral Therapeutics develops non-surgical, self-administered artesunate treatments for HPV-induced pre-cancers and cancers of the cervix, vulva, anus and oropharynx, delivered as vaginal inserts, suppositories or ointment. It is a collaboration between Georgetown University Medical Center and Frantz Medical Group. On ClinicalTrials.gov it is the lead sponsor of 2 trials recorded in OnCo: NCT04098744 (phase 2, Artesunate Vaginal Inserts for the Treatment of Cervical Intraepithelial Neoplasia (CIN...) and NCT06075264 (phase 2, Phase II Study of Artesunate Ointment for the Treatment of Vulvar High Grade Squamous I...). Sponsor and trial facts are from the ClinicalTrials.gov registry; company facts are from the official website.","asOf":"2026-09-17","links":[{"label":"Official website","url":"https://frantzviraltherapeutics.com/"},{"label":"ClinicalTrials.gov: trials led by Frantz Viral Therapeutics","url":"https://clinicaltrials.gov/search?lead=Frantz%20Viral%20Therapeutics%2C%20LLC"}],"tags":["ctgov-sponsor"],"related":[],"cancers":["vaginal","vulvar"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":["nct04098744","nct06075264"],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"provenance":{"editedBy":"OnCo orphan-trial linking round (ClinicalTrials.gov v2 + sponsor websites)","editedOn":"2026-09-17"},"hq":"Mentor, Ohio","country":"US","companyType":"biotech","website":"https://frantzviraltherapeutics.com/","stage":"growth","investors":[],"funding":[]},"route":"/companies/frantz-viral-therapeutics/","neighbours":{"cancer":[{"id":"vaginal","kind":"cancer","name":"Vaginal cancer","route":"/cancers/vaginal/"},{"id":"vulvar","kind":"cancer","name":"Vulvar cancer","route":"/cancers/vulvar/"}],"trial":[{"id":"nct04098744","kind":"trial","name":"Artesunate Vaginal Inserts for the Treatment of Cervical Intraepithelial Neoplasia (CIN2/3)","route":"/trials/nct04098744/"},{"id":"nct06075264","kind":"trial","name":"Phase II Study of Artesunate Ointment for the Treatment of Vulvar High Grade Squamous Intraepithelial Lesions (Vulvar HSIL, VIN2/3)","route":"/trials/nct06075264/"}]}}